Global Medicine for Osteoarthritis Pain Market Size, Share & Trends Analysis Report, By Product Type (Oral and Injection), By End-User (Medical Care and Personal Care), Forecast (2022-2028)

The global medicine for osteoarthritis pain market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Osteoarthritis is referred to as the most common form of arthritis that affects the body mobility and the quality of life of people. There are various forms of medicines available for osteoarthritis pain such as analgesics, that are used for pain treatment. This drug class works by stopping signals in the body that creates pain. Instances of analgesics include Acetaminophen (Tylenol) and Duloxetine (Cymbalta). Acetaminophen (Tylenol) is an over the counter (OTC) analgesic that can be administered orally as a tablet, gel capsule, or liquid concentration. Another class of drugs known as nonsteroidal anti-inflammatory drugs (NSAIDs) are also used for the treatment of osteoarthritis pain. The global medicine for osteoarthritis pain market growth is driven by the increasing prevalence of arthritis coupled with the surge in the number of sports injuries.
Further, the demand for medicine for osteoarthritis pain is most likely to emerge from the population falling in age group of 40 to 70. As per the Arthritis Foundation, in the US, nearly 54.4 million adults (22.7% of all adults) had doctor-diagnosed arthritis during the period, 2013-2015. By 2040, an estimated adult aged 18 years and older with doctor-diagnosed arthritis will be 78.4 million (25.9% of the estimated total adult population) in the US. Such affected population is likely to positively affect the growth of the global medicine for osteoarthritis pain market during the forecast period.

Market Coverage
The market number available for – 2021-2028
Base year- 2021
Forecast period- 2022-2028
Segment Covered- 
By Product Type
By End-User
Regions covered-
North America
Europe
Asia-Pacific
Rest of the World

Top Major Key Players:
Pfizer Inc., Johnson & Johnson Services, Inc., and Bayer AG, among others.

Key questions addressed by the report
What is the market growth rate?
Which segment and region dominate the market in the base year?
Which segment and region will project the fastest growth in the market?
How COVID-19 impacted the market?
Deviation from the pre-COVID-19 forecast
Most affected region and segment
Who is the leader in the market?
How are players addressing challenges to sustain growth?
Where is the investment opportunity?

Global Medicine for Osteoarthritis Pain Market Report by Segment

By Product Type
Oral
Injection
By End-User
Medical Care
Personal Care